Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07444619
Recruiting
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
Phase 1 · United States · 1 site
Registry update: 6 Aug 2026
NCT07549256
Recruiting
Cannabidiol for Pain Relief of Patients With End-stage mCRPC
Phase 2 · Denmark · 1 site
Registry update: 16 Sept 2026
NCT07507760
Recruiting
Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients
Phase 2 · Spain, Portugal · 20 sites
Registry update: 22 Sept 2026
2025-523238-17-00
Recruiting
A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy
Phase 2 · Spain, Portugal · 21 sites
Registry update: 14 Sept 2026
NCT07745920
Recruiting
Managing Depressive Symptoms in ADPKD
Not applicable · United States · 1 site
Registry update: 7 Aug 2026
NCT07702461
Recruiting
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Not applicable · United States · 1 site
Registry update: 24 Jul 2026
NCT07879755
Recruiting
An Extension Trial of GW 906 in Participants With Essential Hypertension
Not applicable · China · 1 site
Registry update: 19 Oct 2026
NCT07781072
Recruiting
Sintilimab Plus Hypofractionated Radiotherapy Followed by Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 24 Aug 2026
NCT07710105
Recruiting
Ocrevus Zunovo for MS: Mixed Methods
Not applicable · United States · 1 site
Registry update: 20 Jul 2026
NCT07635316
Recruiting
A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Not applicable · United States · 1 site
Registry update: 15 Oct 2026
NCT06996119
Recruiting
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Phase 1 · United States · 1 site
Registry update: 1 Jul 2026
NCT07613593
Recruiting
INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease
Not applicable · United Kingdom · 1 site
Registry update: 6 Jul 2026
2025-522883-34-00
Recruiting
PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Phase 4 · Netherlands · 11 sites
Registry update: 11 May 2026
NCT07572773
Recruiting
CHAMP Lung Cancer Screening Program
Not applicable · United States · 3 sites
Registry update: 16 Jun 2026
NCT06666712
Recruiting
Chronic CED of TPT for Recurrent Malignant Glioma
Phase 1 · United States · 1 site
Registry update: 15 Jun 2026
NCT07881016
Recruiting
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Not applicable · France · 16 sites
Registry update: 19 Oct 2026
NCT07676461
Recruiting
Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
Not applicable · Colombia · 1 site
Registry update: 7 Jul 2026
NCT07590193
Recruiting
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Phase 1 · United States · 2 sites
Registry update: 3 Aug 2026
NCT07524036
Recruiting
Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.
Not applicable · France · 1 site
Registry update: 18 Aug 2026
NCT07841574
Recruiting
HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC
Phase 2 · China · 1 site
Registry update: 25 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.